slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
88,07 EUR | +1,15% | -0,44% | -1,59% |
26/06 | FDA keurt therapie van Verona Pharma voor 'rokerslongen' goed | RE |
26/06 | Sanofi-medicijnontwikkelaar Formation Bio haalt $372 miljoen op | MT |
Omzet 2024 * | 46,36 mld. 49,51 mld. | Omzet 2025 * | 49,93 mld. 53,32 mld. | Marktkapitalisatie | 113 mld. 121 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 7,08 mld. 7,56 mld. | Nettowinst (verlies) 2025 * | 8,69 mld. 9,28 mld. | EV/omzet 2024 * | 2,6 x |
Nettoschuld 2024 * | 6,99 mld. 7,47 mld. | Nettoschuld 2025 * | 2,37 mld. 2,53 mld. | EV/omzet 2025 * | 2,32 x |
K/w-verhouding 2024 * |
16,3
x | K/w-verhouding 2025 * |
13,1
x | Werknemers | 86.088 |
Dividendrendement 2024 * |
4,26% | Dividendrendement 2025 * |
4,48% | Vrij verhandelbaar | 87,13% |
Recentste transcriptie over Sanofi
1 dag | +1,15% | ||
1 week | -0,44% | ||
Lopende maand | -1,78% | ||
1 maand | -1,78% | ||
3 maanden | +1,23% | ||
6 maanden | -1,54% | ||
Lopend jaar | -1,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 01-09-19 |
Madeleine Roach
COO | Chief Operating Officer | 40 | 01-01-22 |
Chief Tech/Sci/R&D Officer | 51 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 01-05-14 |
Lise Kingo
BRD | Director/Board Member | 62 | 28-04-20 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 22-05-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-06-24 | 91,7 | +0,71% | 2 006 |
25-06-24 | 91,05 | +0,47% | 182 |
24-06-24 | 90,62 | +4,15% | 1 684 |
21-06-24 | 87,01 | -1,20% | 458 |
20-06-24 | 88,07 | +1,15% | 557 |
slotkoers Borsa Italiana, 20 juni 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,61% | 815 mld. | |
+44,25% | 654 mld. | |
-6,33% | 354 mld. | |
+20,62% | 337 mld. | |
+10,44% | 302 mld. | |
+18,45% | 247 mld. | |
+2,09% | 229 mld. | |
+13,03% | 219 mld. | |
+8,61% | 171 mld. |